US Patent 7138377 Topoisomerase inhibitors
Patent 7138377 was granted and assigned to Bristol-Myers Squibb on November, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+231 characters)
Article
Patent abstract
The present invention concerns novel sugar derivatives of indolocarbazoles and pharmaceutical formulations thereof which exhibit topoisomerase-I activity and are useful in inhibiting the proliferation of tumor cells.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07138377 Topoisomerase inhibitors US Patent 7138377 Topoisomerase inhibitors
Infobox
Patent Number
0713837700
Patent Number
713837700
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071383770
Date of Patent
November 21, 2006
0Patent Application Number
104348120
Date Filed
May 9, 2003
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071383770
Date of Patent
November 21, 2006
0Patent Application Number
104348120
Date Filed
May 9, 2003
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07138377 Topoisomerase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07138377
Date of patent
November 21, 2006
Patent application number
10434812
Date Filed
May 9, 2003
Patent primary examiner
Find more entities like US Patent 7138377 Topoisomerase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
